SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: Correlation with fraction absorbed in humans

Journal of Medicinal Chemistry

Volumn 43, Issue 11, 2000, Pages 2083-2086

  Danelian, Ernest ^a   Karlén, Anders ^b   Karlsson, Robert ^a   Winiwarter, Susanne ^b   Hansson, Anna ^a   Löfås, Stefan ^a   Lennernäs, Hans ^b   Hämäläinen, Markku D ^a  

^a Technical Operations   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; LIPOSOME;

BIOSENSOR; CORRELATION FUNCTION; DRUG ABSORPTION; HUMAN; INTESTINE ABSORPTION; LETTER; SURFACE PROPERTY;

HUMANS; INTESTINAL ABSORPTION; LIPOSOMES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PREDICTIVE VALUE OF TESTS; SURFACE PLASMON RESONANCE;

EID: 0034213343     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991156g     Document Type: Letter

References (16)

1. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
2. Fagerholm, U.; Johansson, M.; Lennernäs, H. Comparison between permeability coefficients in rat and human jejunum. Pharm. Res. 1996, 13, 1336-1342.
3. Lennernäs, H.; Nylander, S.; Ungell, A.-L. Jejunal permeability: A comparison between the Ussing chamber technique and the single-pass perfusion in humans. Pharm. Res. 1997, 14, 667-671.
4. Lundahl, P.; Beigi, F. Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions. Adv. Drug Deliv. Rev. 1997, 23, 221-227.
5. Balon, K.; Riebesehl, B. U.; Müller, B. W. Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm. Res. 1999, 16, 882-888.
6. Pidgeon, C.; Ong, S.; Liu, H.; Qiu, X.; Pidgeon, M.; Dantzig, A. H.; Munroe, J.; Hornback, W. J.; Kasher, J. S.; Glunz, L.; Szczerba, T. IAM chromatography: An in vitro screen for predicting drug membrane permeability. J. Med. Chem. 1995, 38, 590-594.
7. Kansy, M.; Senner, F.; Gubernator, K. Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 1998, 41, 1007-1010.
8. Winiwarter, S.; Bonham, N. M.; Ax, F.; Hallberg, A.; Lennernäs, H.; Karlén, A. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 1998, 41, 4939-4949.
9. Palm, K.; Stenberg, P.; Luthman, K.; Artursson, P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 1997, 14, 568-571.
10. Lennernäs, H. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J. Pharm. Pharmacol. 1997, 49, 627-638.
11. Lennernäs, H. Human intestinal permeability. J. Pharm. Sci. 1998, 87, 403-410.
12. Clark's Isolation and Identification of Drugs; Moffat, A. C., Ed.; The Pharmaceutical Press: London, 1986.
13. Therapeutic Drugs; Dollery, C., Ed.; Churchill Livingstone: Edinburgh, 1991.
14. eff values (ref 8) according to ref 2.
15. Jack, D. B. Handbook of Clinical Pharmacokinetic data; Macmillan Publishers Ltd.: England, 1994.
16. Liang, E.; Yazdanian, M. Investigation of sulfasalazine as a substrate of efflux pumps in caco-2 cells. Pharm. Sci. 1999, 1, 2564.